In conjunction with the company’s 40th anniversary, Gore has announced that it has now sold 40 million devices worldwide. The milestone comes as the company showcases its latest innovations and achievements at the 2015 VEITHsymposium (17–21 November, New York, USA).
The medical products division of Gore was formed by Bill Gore with the intent to design an ideal substitute for a human blood vessel using Gore-Tex ePTFE. Forty years later, Gore is an industry leader with more than 40 million devices sold designed to treat patients along the entire length of the body.
At VEITHsymposium 2015, Gore is announcing developments to its diverse portfolio of products, including clinical trial developments, as well beginning the nominations for the 2016-2017 “Pioneers in Performance” award.
The Excluder iliac branch endoprosthesis has exceeded 1,000 implants worldwide; a milestone that comes two years after the device received the CE mark in Europe. The device is currently commercially available in Europe and Australia, available through special access in Canada and is involved in a clinical trial in the USA.
Gore is also celebrating the sixth year of its Pioneers in Performance awards, honouring physicians responsible for driving medical innovation and improving clinical and patient outcomes. The Pioneers in Performance Awards recognise physicians for their commitment to advancing vascular and endovascular therapy and minimally invasive treatment options for patients across the globe. These specialties include aortic and lower-limb bypass, and dialysis access surgery.
